Literature DB >> 17606842

The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors.

Francesco Scolari1, Pietro Ravani, Rossella Gaggi, Marisa Santostefano, Cristiana Rollino, Nevio Stabellini, Loredana Colla, Battista Fabio Viola, Paolo Maiorca, Chiara Venturelli, Stefano Bonardelli, Pompilio Faggiano, Brendan J Barrett.   

Abstract

BACKGROUND: Atheroembolic renal disease (AERD) is caused by showers of cholesterol crystals released by eroded atherosclerotic plaques. Embolization may occur spontaneously or after angiographic/surgical procedures. We sought to determine clinical features and prognostic factors of AERD. METHODS AND
RESULTS: Incident cases of AERD were enrolled at multiple sites and followed up from diagnosis until dialysis and death. Diagnosis was based on clinical suspicion, confirmed by histology or ophthalmoscopy for all spontaneous forms and for most iatrogenic cases. Cox regression was used to model time to dialysis and death as a function of baseline characteristics, AERD presentation (acute/subacute versus chronic renal function decline), and extrarenal manifestations. Three hundred fifty-four subjects were followed up for an average of 2 years. They tended to be male (83%) and elderly (60% >70 years) and to have cardiovascular diseases (90%) and abnormal renal function at baseline (83%). AERD occurred spontaneously in 23.5% of the cases. During the study, 116 patients required dialysis, and 102 died. Baseline comorbidities, ie, reduced renal function, presence of diabetes, history of heart failure, acute/subacute presentation, and gastrointestinal tract involvement, were significant predictors of event occurrence. The risk of dialysis and death was 50% lower among those receiving statins.
CONCLUSIONS: Clinical features of AERD are identifiable. These make diagnosis possible in most cases. Prognosis is influenced by disease type and severity.

Entities:  

Mesh:

Year:  2007        PMID: 17606842     DOI: 10.1161/CIRCULATIONAHA.106.680991

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  27 in total

1.  Low-density lipoprotein apheresis ameliorates monthly estimated glomerular filtration rate declines in patients with renal cholesterol crystal embolism.

Authors:  Keiji Hirai; Susumu Ookawara; Haruhisa Miyazawa; Kiyonori Ito; Yuichirou Ueda; Yoshio Kaku; Taro Hoshino; Izumi Yoshida; Kaoru Tabei
Journal:  J Artif Organs       Date:  2014-11-04       Impact factor: 1.731

2.  Gross proteinuria and subacute renal failure after coronary angiography - a case report of cholesterol crystal embolization.

Authors:  Peter Biesenbach; Thomas Gremmel; Walter H Hörl; Renate Kain; Marcus D Säemann
Journal:  Wien Klin Wochenschr       Date:  2010-04       Impact factor: 1.704

3.  Efficacy of low-density lipoprotein apheresis combined with corticosteroids for cholesterol crystal embolism.

Authors:  Katsuya Ishiyama; Toshinobu Sato; Takuhiro Yamaguchi; Yoshio Taguma
Journal:  Clin Exp Nephrol       Date:  2016-04-21       Impact factor: 2.801

Review 4.  Aortic atherosclerosis and embolic events.

Authors:  Muhamed Saric; Itzhak Kronzon
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

Review 5.  Atherosclerotic-nephropathy: an updated narrative review.

Authors:  Mariadelina Simeoni; Silvio Borrelli; Carlo Garofalo; Giorgio Fuiano; Ciro Esposito; Alessandro Comi; Michele Provenzano
Journal:  J Nephrol       Date:  2020-04-08       Impact factor: 3.902

Review 6.  Revascularization options in patients with chronic kidney disease.

Authors:  Guha Ashrith; MacArthur A Elayda; James M Wilson
Journal:  Tex Heart Inst J       Date:  2010

7.  Atheroembolic renal disease with rapid progression and fatal outcome.

Authors:  Bernardo Faria; Joana Vidinha; Cátia Pêgo; Jesus Garrido; Sérgio Lemos; Carla Lima; Giovanni Sorbo; Edgar Lorga Gomes; Teresa Carvalho; Paulo Loureiro; Tânia Sousa
Journal:  Clin Exp Nephrol       Date:  2010-11-11       Impact factor: 2.801

8.  Lack of association between dialysis modality and outcomes in atheroembolic renal disease.

Authors:  Pietro Ravani; Rossella Gaggi; Cristiana Rollino; Marisa Santostefano; Nevio Stabellini; Loredana Colla; Nadia Dallera; Sara Ravera; Sergio Bove; Pompilio Faggiano; Francesco Scolari
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 8.237

Review 9.  The cholesterol emboli syndrome in atherosclerosis.

Authors:  Adriana Quinones; Muhamed Saric
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

10.  Cholesterol-crystal embolism presenting with delayed graft function and impaired long-term function in renal transplant recipients: two case reports.

Authors:  Rainer U Pliquett; Aida Asbe-Vollkopf; Ernst H Scheuermann; Elisabeth Gröne; Michael Probst; Helmut Geiger; Ingeborg A Hauser
Journal:  J Med Case Rep       Date:  2009-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.